Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-06

Clinical Trial Update: T-regulatory Cells in ALS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating T-regulatory cells in Amyotrophic Lateral Sclerosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 2 | Status: ACTIVE_NOT_RECRUITING